Depreotide: A Somatostatin Receptor Imaging Agent for Pulmonary Nodule Assessment and Metastasis Detection
Accurately assess lung nodules and detect cancer spread with this advanced peptide imaging agent.
Get a Quote & SampleProduct Core Value
Depreotide Peptide
Depreotide is a specialized peptide analog designed to target somatostatin receptors, which are frequently overexpressed in various types of tumors, particularly lung cancers. Its ability to preferentially bind to somatostatin receptor subtypes 2, 3, and 5 makes it an invaluable tool in the field of diagnostic imaging.
- Leverage somatostatin receptor imaging agent capabilities to accurately assess lung tumors, aiding in the differentiation between malignant and benign pulmonary nodules before invasive procedures like biopsies.
- Benefit from this non-invasive cancer imaging solution that enhances the precision of oncological diagnostics.
- Utilize Depreotide for renal cell carcinoma lung metastasis detection, offering crucial insights for treatment planning.
- Experience improved diagnostic accuracy through targeted cancer therapies guided by Depreotide's receptor-specific binding properties.
Advantages Offered by the Product
Enhanced Diagnostic Precision
Depreotide's specific binding to somatostatin receptors allows for superior accuracy in malignant vs benign nodule assessment, providing clinicians with reliable data.
Minimally Invasive Approach
As a non-invasive cancer imaging agent, Depreotide offers a safer alternative to traditional biopsy methods for initial pulmonary nodule evaluations.
Broad Applicability in Oncology
Beyond primary lung issues, Depreotide is effective for pulmonary metastases detection, including those from renal cell carcinoma, broadening its clinical utility.
Key Applications
Pulmonary Nodule Assessment
Utilize Depreotide as a precise somatostatin receptor imaging agent to evaluate solitary pulmonary nodules and determine their nature.
Cancer Metastasis Detection
Employ Depreotide for the sensitive detection of secondary lung cancers, such as renal cell carcinoma lung metastasis detection.
Oncology Imaging Guidance
Leverage this advanced peptide analog for lung nodules to guide further diagnostic and therapeutic strategies in cancer patients.
Tumor Receptor Profiling
Assess tumor expression of somatostatin receptors with Depreotide, aiding in the selection of targeted therapies.